Sort
3,198 grants matching “mrna vaccine”
Core B: GMP Cell and RNA Manufacturing
$1,373,779Bruce L. Levine · University Of Pennsylvania · P01 · FY2017 · CA
Structure-Function Studies of the HIV-1 Envelope Glycoproteins and Development of VLP-forming vaccine strategies for HIV-1
$1,373,021Paolo Lusso · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
Antigen Processing And Presentation In The Intestine
$1,371,624Brian Kelsall · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI
Early Life Vaccination to Prevent HIV acquisition during Adolescence
$1,370,057Sallie R. Permar · Weill Medical Coll Of Cornell Univ · P01 · FY2024 · AI
A Novel Class of Synthetic Receptors to Empower the Age of mRNA Therapies
$1,350,770Xiaojing J Gao · Stanford University · DP2 · FY2023 · EB
Understanding the Role of the Host Response in HIVSIV Infection
$1,346,823Genoveffa Franchini · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
Fox COBRE Phase II Admin Core
$1,343,022Joseph M Fox · University Of Delaware · P20 · FY2024 · GM
Closing Research Gaps in Antiretroviral Treatment for Pregnant Women and Infants Living with HIV
$1,340,804Roger L Shapiro · Harvard School Of Public Health · P01 · FY2021 · HD
Transporting Stable RNA Across the Blood-Brain Barrier for On-Demand Translation
$1,323,950Jessica Marie Larsen · Clemson University · DP2 · FY2025 · NS
Center of Research Translation on the Osteoimmunology of Bone Infection (CoRTOBI)
$1,322,427Edward M Schwarz · University Of Rochester · P50 · FY2024 · AR
Development of Nipah virus mRNA vaccine
$1,317,404Rosemarie Mason · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
Early Life Vaccination to Prevent HIV acquisition during Adolescence
$1,307,799Sallie R. Permar · Duke University · P01 · FY2020 · AI
Center of Research Translation on the Osteoimmunology of Bone Infection (CoRTOBI)
$1,304,334Edward M Schwarz · University Of Rochester · P50 · FY2023 · AR
Prevention of AIDS
$1,300,391Barbara Felber · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
CPTR - Mass Spectrometry Unit
$1,295,034Lisa Jenkins · Division Of Basic Sciences - Nci · ZIC · FY2024 · CA
COVID-19: immune response and systems vaccinology
$1,291,106Lothar Hennighausen · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2023 · DK
Enhancing durability of V3 glycan vaccine responses in rhesus macaques
$1,285,304Jon Steichen · Scripps Research Institute, The · R01 · FY2025 · AI
Project 2: Current Good Manufacture Practices (CGMP) Production of Nucleoside-Modified mRNAs Encoding HIV-1 Envelopes
$1,280,922Frederick Porter · Duke University · U19 · FY2021 · AI
Discovery of Adjuvants for mRNA Vaccines
$1,280,295Dennis Carson · University Of California, San Diego · N01 · FY2025 · AI
Project 1: Development of Nucleoside-Modified mRNAs Encoding Sequential HIV-1 Envelopes for Initiation of V3-glycan Neutralizing Antibody Lineages
$1,272,291Barton F Haynes · Duke University · U19 · FY2018 · AI
Monoclonal antibody isolation and characterization
$1,270,555Rosemarie Mason · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
Mucosal Immunology and Virology
$1,268,609Neeltje Van Doremalen · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
Project 1
$1,264,760Richard Thomas Wyatt · Scripps Research Institute, The · P01 · FY2021 · AI
A phase I study of RNA-lipid particle vaccines for newly-diagnosed glioblastoma, IND19304 08/21/2020
$1,262,498Elias Sayour · University Of Florida · R01 · FY2022 · FD
Contributions of durable, high-avidity T-cell responses to protection achieved using the Opti-FliP vaccine regimen
$1,260,330Dennis J Hartigan-O'Connor · University Of California At Davis · P01 · FY2025 · AI